$ Value
$0
Shares
7,500
Price
$0
Filed
Apr 3
Insider
Name
Burrows Scott L
Title
Chief Financial Officer
CIK
0001853327
Roles
Transaction Details
Transaction Date
2026-04-01
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
394,857
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.69 to $49.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.76 to $50.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer. | This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Filing Info
Burrows Scott L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | SYRE | M | $109K |
| 2026-04-01 | SYRE | ▼ | $305K |
| 2026-04-01 | SYRE | ▼ | $65K |
| 2026-04-01 | SYRE | M | $0 |
| 2025-09-02 | SYRE | ▼ | $300K |
Other Insiders at SYRE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Turtle Cameron
Chief Executive Officer
|
— | $740K | 2026-04-01 |
|
Burrows Scott L
Chief Financial Officer
|
— | $370K | 2026-04-01 |
|
Sloan Sheldon
Chief Medical Officer
|
— | $398K | 2026-04-01 |